Frequency Therapeutics, Inc.·4

Apr 22, 4:23 PM ET

McCubbin Quentin 4

4 · Frequency Therapeutics, Inc. · Filed Apr 22, 2021

Insider Transaction Report

Form 4
Period: 2021-04-20
McCubbin Quentin
Chief Manufacturing Officer
Transactions
  • Award

    Restricted Stock Unit

    2021-04-20+35,00035,000 total
    Common Stock (35,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
  • [F2]The restricted stock units will vest as to 50% on February 14, 2022 and 50% on July 4, 2022.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT